SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850261-19-000020
Filing Date
2019-05-15
Accepted
2019-05-15 17:00:50
Documents
99
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srne3301910-q.htm 10-Q 1168172
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 12300
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 12114
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 13190
  Complete submission text file 0000850261-19-000020.txt   9153397

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20190331.xml EX-101.INS 1781125
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20190331.xsd EX-101.SCH 85851
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20190331_cal.xml EX-101.CAL 119418
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20190331_def.xml EX-101.DEF 510862
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20190331_lab.xml EX-101.LAB 1029734
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20190331_pre.xml EX-101.PRE 695253
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 19829391
SIC: 8731 Services-Commercial Physical & Biological Research